TURKVEN
Established in 2000, Turkven is the leading private equity firm in Turkey, with over $1.5 billion of AUM and over $5 billion of investments.
Turkven has a culture of company-building and sectoral expertise, underpinned by the first hand experience from its portfolio of leading firms across industries.
Turnspire Capital Partners
Turnspire Capital Partners is a private investment firm focused on providing special situations solutions to the lower middle market in North America.
Through corporate carve-outs, restructurings, or buyouts, Turnspire's goal is to acquire high-quality businesses that have reached strategic, operational or financial inflection points and stand to benefit from our hands-on, operationally focused approach. We seek to create value by working with like-minded operating executives to drive sustainable improvements in controllable costs, margins and cash flow.
Turnspire’s investment philosophy is predicated on creating value through operational improvements rather than financial leverage. We strive to make each of our companies best-in-class in their respective industry niche, and then to grow the businesses through organic initiatives or strategic acquisitions.
Turnspire's Operating Executive Network is a unique platform where the firm leverages partnerships with successful executives that share our passion solving operating and strategic challenges in order to drive business transformation.
Further information is available at www.turnspirecap.com.
Tuscan Ventures
Tuscan Ventures Pvt. Ltd., is a firm head quartered in Mumbai. Tuscan is focussed on providing capital & operational expertise to build business in Financial Services, Supply Chain Services, Food & Agriculture.
The team at Tuscan Ventures together houses several years of operational, investment and entrepreneurial experience creating a robust platform from which significant levels of hands-on assistance - financial, strategic and operational - is delivered to its own and investee companies.
Tusk Venture Partners
Tusk Venture Partners is a venture capital firm based in New York City, founded in 2015. The firm specializes in investing in early-stage technology companies operating in highly regulated markets. With a team of three professionals, Tusk Venture Partners offers a unique platform that combines venture capital with political consulting and regulatory execution, helping founders navigate regulatory risks effectively.
The firm focuses on sectors such as consumer, digital health, enterprise, fintech, gaming, and transportation. Tusk Venture Partners typically invests in Seed and Series A stages, with check sizes ranging from $500K to $10M. The firm primarily invests in North America, particularly in the USA and Canada. As a Registered Investment Adviser, Tusk Venture Partners is actively seeking new investments.
Notable investments by Tusk Venture Partners include Coinbase - a cryptocurrency exchange, FanDuel - a sports betting company, Lemonade - an insurance company, Lithic - a card issuing platform, and Ro - a healthcare technology company.
Tusk Ventures
Tusk Ventures is a venture capital firm based in New York and Chicago, known for its expertise in regulatory, communications, and strategic development for startups and growing businesses. Founded by Bradley Tusk, a former political consultant, the firm consists of a diverse team of investors, operators, public officials, lawyers, and communications experts. Tusk Ventures distinguishes itself by providing startups with strategic guidance to navigate regulatory landscapes, drawing from substantial political expertise.
Tusk Ventures invests in early-stage companies with a focus on addressing regulatory challenges. They primarily target sectors that face significant policy or regulatory barriers. The firm has raised and invested through four funds, offering expertise in navigating these intricate environments. They hold equity in their portfolio companies, guiding them through critical growth phases while focusing on North American geography.
Notable investments by Tusk Ventures include Uber - ride-sharing service, FanDuel - fantasy sports platform, CLEAR - biometric identity verification, Ro - telehealth services, and Doctronic - healthcare technology. These investments showcase their capability in managing regulatory complexities across different sectors.
TUZ Ventures
TUZ Ventures is a venture capital firm based in Astana, Kazakhstan, founded in 2019 by Fabio Ribeiro and a team of Silicon Valley entrepreneurs. The firm focuses on early-stage investments in Central Asia and the Caucasus, leveraging a diverse team of seasoned VCs and local experts. TUZ Ventures is known for its strategic approach to penetrating untapped frontier markets, having previously succeeded in regions like Indonesia and Nigeria.
The firm primarily invests in sectors such as fintech, logistics, artificial intelligence, e-government, and blockchain. It targets early-stage companies and operates with a focus on the Kyrgyz Republic, Turkmenistan, Afghanistan, Kazakhstan, Uzbekistan, Azerbaijan, Tajikistan, Mongolia, Armenia, Georgia, and Pakistan. TUZ Ventures does not publicly disclose specific check sizes but is known for its active involvement in the growth of its portfolio companies.
Notable investments by TUZ Ventures include zypl.ai - financial software, Expper Technologies - other hardware, and Puzl - business/productivity software. The firm has made 20 investments and achieved 20 exits, demonstrating its active role in the venture capital landscape of Central Asia.
TVCA
The Taiwan Venture Capital Association (TVCA) is an organization that serves as a platform for venture capital firms and related industries in Taiwan to exchange information and promote best practices. It operates out of Taipei and plays a crucial role in shaping the venture capital landscape in the region. The association is governed by a board consisting of key players in the industry, who contribute their expertise to various initiatives that foster collaboration between capital providers and startups.
TVCA focuses on creating an environment conducive to the growth of venture capital in Taiwan. This involves participating in policy advocacy, organizing industry events, and establishing partnerships that benefit its members. The association does not strictly invest in individual companies but rather supports the ecosystem that enables venture investments to flourish. Its initiatives include educational events and competitions aimed at promoting innovation and entrepreneurship across various sectors.
While TVCA itself does not directly invest or maintain a portfolio of startup companies, it has been instrumental in promoting and facilitating events and initiatives that benefit the venture capital community in Taiwan. Through its activities, it contributes to the vibrant startup ecosystem by encouraging investment and collaboration among different stakeholders.
TVM Capital Healthcare
TVM Capital Healthcare is an emerging markets-focused healthcare private equity investment firm. The organization invests growth capital and focuses on specialized healthcare services, digital health solutions, pharmaceuticals, medical devices, and diagnostics. Investment and operating partners have strong track records in international healthcare M&A and operations. Headquartered in Singapore and Dubai, with representative offices in Munich and Boston, the firm partners with Southeast Asian management teams to build sector champions. TVM Capital Healthcare’s investment approach combines strong commercial value creation and returns with responsible investing.
The firm’s comprehensive ESG framework contributes to the creation of impactful, sustainable, and well-governed companies that deliver excellent healthcare services, continued growth, and create high-quality jobs for healthcare professionals in a fair and diverse workplace. TVM Capital Healthcare is a UN PRI signatory since 2015 and a long-standing member of GPCA and recently EPiHC (Ethical Principles in healthcare) an IFC (International Finance Corporation) Initiative, as well as 2X Global and GIIN.
TVM Capital Life Science
TVM Capital Life Science is a venture capital firm based in Munich, Germany, founded in 1983. The firm specializes in life sciences investments, focusing on early-stage therapeutics and commercial-stage medtech, diagnostics, and digital health products. TVM Capital Life Science has a strategic relationship with Eli Lilly and Company, which enhances its ability to support innovative healthcare companies. The team comprises experienced professionals with over 100 years of combined venture capital and industry expertise.
The firm invests primarily in the life sciences sector, including biotechnology, pharmaceuticals, and medical devices. TVM Capital Life Science typically invests in Series A and B rounds, with a minimum investment size of $1 million. The firm operates globally, with a focus on Europe and North America, and manages assets worth approximately 900 million euros. Notable funds include TVM Life Science Innovation II, a $478 million fund launched in 2018.
TVM Capital Life Science's portfolio includes companies such as Access Vascular - surgical devices, Kent Imaging - diagnostic equipment, and LAmAb Biologics - drug discovery. The firm has a track record of successful exits, including IPOs and acquisitions, highlighting its role as a key player in the life sciences venture capital landscape.
TVM Capital MENA
TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care.
TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.
The TVM investment team has worked together for over a decade to effectively utilize this innovative approach to maximize returns for investors and finance new therapies and technologies to meaningfully improve patient lives.